Publicacións en colaboración con investigadores/as de Memorial Sloan Kettering Cancer Center (38)

2023

  1. A likelihood ratio approach for utilizing case-control data in the clinical classification of rare sequence variants: Application to BRCA1 and BRCA2

    Human Mutation, Vol. 2023

  2. Aggregation tests identify new gene associations with breast cancer in populations with diverse ancestry

    Genome Medicine, Vol. 15, Núm. 1

  3. Association of the CHEK2 c.1100delC variant, radiotherapy, and systemic treatment with contralateral breast cancer risk and breast cancer-specific survival

    Cancer Medicine, Vol. 12, Núm. 15, pp. 16142-16162

  4. Evaluation of European-based polygenic risk score for breast cancer in Ashkenazi Jewish women in Israel

    Journal of Medical Genetics, Vol. 60, Núm. 12, pp. 1186-1197

  5. Hypofractionated Radiation Therapy (Hypo-RT) for the Treatment of Localized Bladder Cancer

    Bladder Cancer, Vol. 9, Núm. 2, pp. 141-150

2022

  1. Common variants in breast cancer risk loci predispose to distinct tumor subtypes

    Breast Cancer Research, Vol. 24, Núm. 1

  2. Correction to: Salvage resection plus cesium-131 brachytherapy durably controls post-SRS recurrent brain metastases (Journal of Neuro-Oncology, (2022), 10.1007/s11060-022-04101-9)

    Journal of Neuro-Oncology

  3. Incorporating progesterone receptor expression into the PREDICT breast prognostic model

    European Journal of Cancer, Vol. 173, pp. 178-193

  4. Patient-specific radiological protection precautions following Cs collagen embedded Cs-131 implantation in the brain

    Journal of Applied Clinical Medical Physics, Vol. 23, Núm. 10

  5. Physical activity, sedentary time and breast cancer risk: a Mendelian randomisation study

    British Journal of Sports Medicine, Vol. 56, Núm. 20, pp. 1157-1170

  6. Salvage resection plus cesium-131 brachytherapy durably controls post-SRS recurrent brain metastases

    Journal of Neuro-Oncology, Vol. 159, Núm. 3, pp. 609-618

2021

  1. A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers

    Nature Communications, Vol. 12, Núm. 1

  2. Application of community detection algorithm to investigate the correlation between imaging biomarkers of tumor metabolism, hypoxia, cellularity, and perfusion for precision radiotherapy in head and neck squamous cell carcinomas

    Cancers, Vol. 13, Núm. 15

  3. Diffusion and Perfusion MRI Predicts Response Preceding and Shortly After Radiosurgery to Brain Metastases: A Pilot Study

    Journal of Neuroimaging, Vol. 31, Núm. 2, pp. 317-323

  4. Erratum: Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers (Nature communications (2021) 12 1 (1078))

    Nature communications

  5. Functional annotation of the 2q35 breast cancer risk locus implicates a structural variant in influencing activity of a long-range enhancer element

    American Journal of Human Genetics, Vol. 108, Núm. 7, pp. 1190-1203

  6. Mendelian randomisation study of smoking exposure in relation to breast cancer risk

    British Journal of Cancer, Vol. 125, Núm. 8, pp. 1135-1145

  7. Multi-site, multi-platform comparison of MRI T1 measurement using the system phantom

    PLoS ONE, Vol. 16, Núm. 6 June

  8. Quantifying clinical severity of physics errors in high-dose rate prostate brachytherapy using simulations

    Brachytherapy, Vol. 20, Núm. 5, pp. 1062-1069

2020

  1. Cumulative Burden of Colorectal Cancer–Associated Genetic Variants Is More Strongly Associated With Early-Onset vs Late-Onset Cancer

    Gastroenterology, Vol. 158, Núm. 5, pp. 1274-1286.e12